B+
Bull case
20%
Probability
Target price
$8.50
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
FHTX
Foghorn TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
FHD-909 is advancing through Phase 1, Foghorn retains multiple wholly owned oncology and immunology programs, and approximately $168 million of cash, cash equivalents, and marketable securities supports runway into the first half of 2028 [#SEC-8K-2026-08-06].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +27.3.
What can break
2027 IND targets and pipeline expansion may be delayed or deprioritized.
Momentum
82
Value
41
Sentiment
83
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.50 · Bull $8.50 · Bear $2.75Analysis 2026-08-06; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-06 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $11.44
Why
Momentum82 · Δ7d -13.2
Value41 · Δ7d 0.0
Sentiment83 · Δ7d +27.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +27.3.
Contradictions & invalidation
- • 2027 IND targets and pipeline expansion may be delayed or deprioritized.
- • Early-stage clinical programs may fail to demonstrate efficacy or tolerability.
- • The lead asset remains early clinical stage with no human efficacy outcome in the supplied evidence.
Catalyst clock
2026-08-10
Post-earnings expectation uncertainty
Lead driver: Sentiment · See AI snapshot
Momentum
82
9% active weight
Current posture
7d trendSoftening
Δ7d
-13.2
Δ21d
-15.3
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
83
62% active weight
Current posture
7d trendImproving
Δ7d
+27.3
Δ21d
+42.8
Why this grade
Composite grade A. Momentum 82.4 / Value 41.2 / Sentiment 83.2
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-06. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$5.50
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$2.75
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$400.26M
Beta
3.02
Shares Out
59.39M
P/E (TTM) · Derived
-5.7
P/S (TTM)
11.49
P/FCF (TTM) · Derived
-5.15
Rev YoY
+112.7%
EPS YoY
-64.3%
Gross Margin
+94.2%
Op Margin
-186.4%
Net Debt
-$118.87M
Current Ratio
3.36
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data